KHAN NAJAT (CEO and President) sold 1.1% of their position (23.59K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $84.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2026ACC: 0002020969-26-000004
DirectorOfficer· CEO and President
Since Feb 2026
-23.59K
Net shares
Net seller
$84.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
23.59K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−23.59K
Price / share
$3.58
Trade value
$84.46K
% of position
1.1%
6/5/2026
2.20M→2.18M
Total
Net shares
−23.59K
Net value
-$84.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/5/2026 | S · Sale | −23.59K | $3.58 | $84.46K | 1.1% | 2.20M | 2.18M |
| Total | −23.59K | -$84.46K | ||||||
Derivative Transactions0
No derivative transactions reported